72.19.Z - Scientific research and development activities
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.91.Z - Intermediary retail sale, non-specialized
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
86.90.D - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 115,7 | 61,4 | -23,3 | -137,9 |
EBITDA | 119,6 | 62,4 | -22,7 | -136,4 |
Short time liabilities | 89,1 | 55,4 | 97,2 | 75,5 |
Equity capital | 537,7 | 599,2 | 571,1 | -4,7 |
Operating profit (EBIT) | 115,7 | 61,4 | -23,2 | -137,8 |
Assets | 626,9 | 654,5 | 668,3 | 2,1 |
Net profit (loss) | 115,7 | 61,4 | -28 | -145,6 |
Cash | 0 | 0,2 | 210 | 98 669,9 |
Net income from sale | 145,8 | 407 | 758 | 86,2 |
Liabilities and provisions for liabilities | 89,1 | 55,4 | 97,2 | 75,5 |
Working assets | 593,1 | 621,8 | 402,9 | -35,2 |
Depreciation | 4 | 1 | 0,5 | -50 |
% | % | % | p.p. | |
Profitability of capital | 21,5 | 10,3 | -4,9 | -15,2 |
Equity capital to total assets | 85,8 | 91,5 | 85,5 | -6 |
Gross profit margin | 79,3 | 15,1 | -3,1 | -18,2 |
EBITDA Margin | 82,1 | 15,3 | -3 | -18,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 223 | 50 | 47 | -3 |
Current financial liquidity indicator | -7,2 | |||
Net dept to EBITDA | -11 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane